Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype

Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype

PurposeGenotyping is fundamental in papillary thyroid cancer (PTC) and helps to enhance diagnosis and prognosis and determine appropriate treatments. The phenotype-genotype association in PTC was previously studied, with BRAF V600E characterizing classic PTC and tall-cell PTC and RAS mutations chara...

Full description

Bibliographic Details
Main Authors:	Jie Zhou, Wei-Ran Wang, Hui-Fang Zhang, Qi-Qi Gao, Wei-Bin Wang, Jian-Hua Zhu, Yu-Shuai Han, Jing Chen, Tong-Hui Ma, Xiao-Yan Zhang, Xiao-Dong Teng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Endocrinology
Subjects:	papillary thyroid carcinoma phenotype gene fusion ETV6-NTRK3 NCOA4-RET
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1138100/full

Similar Items

Case Report: Identification of a novel NTRK3-AJUBA fusion co-existing with ETV6-NTRK3 fusion in papillary thyroid carcinoma
by: Qing-Xiang Yu, et al.
Published: (2023-04-01)

RET rearrangements are relevant to histopathologic subtypes and clinicopathological features in Thai papillary thyroid carcinoma patients
by: Thitima Khonrak, et al.
Published: (2023-04-01)

A case of thyroid carcinoma with mucinous features harboring ETV6-NTRK3 fusion: Expanding the morphologic spectrum of NTRK-rearranged thyroid carcinoma
by: Khaled A. Murshed, et al.
Published: (2022-06-01)

Systematic population-based identification of NTRK and RET fusion-positive thyroid cancers
by: Markus Eszlinger, et al.
Published: (2023-01-01)

RET/PTC translocations and clinico-pathological features in human papillary thyroid carcinoma (PTC)
by: Cristina eRomei, et al.
Published: (2012-04-01)

Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma
by: Margherita Nannini, et al.
Published: (2022-12-01)

Genomic characterization of high-recurrence risk papillary thyroid carcinoma in a southern Chinese population
by: Min Li, et al.
Published: (2020-05-01)

Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma
by: Elisa eMenicali, et al.
Published: (2012-05-01)

A case of primary lung adenocarcinoma mimicking metastatic papillary thyroid carcinoma
by: Akira Tanaka, et al.
Published: (2024-02-01)

Durable Disease Control by RET Inhibitor Selpercatinib in a Heavily Pre-Treated RET Fusion-Positive Papillary Thyroid Cancer
by: Tomoya Yokota
Published: (2022-09-01)

NTRK Fusions, from the Diagnostic Algorithm to Innovative Treatment in the Era of Precision Medicine
by: Federica Zito Marino, et al.
Published: (2020-05-01)

Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy
by: María San Román Gil, et al.
Published: (2020-07-01)

Coexistence of Medullary and Papillary Thyroid Carcinomas Detected Incidentally
by: Ensar Aydemir, et al.
Published: (2021-03-01)

Simultaneous occurrence of medullary and papillary thyroid microcarcinomas: a case series and review of the literature
by: Adnan Zaina, et al.
Published: (2013-01-01)

CRLF1–MYH9 Interaction Regulates Proliferation and Metastasis of Papillary Thyroid Carcinoma Through the ERK/ETV4 Axis
by: Shi-Tong Yu, et al.
Published: (2020-08-01)

Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review
by: Poupak Fallahi, et al.
Published: (2023-11-01)

Rethinking the role of oncogenes in papillary thyroid cancer initiation
by: Mario eVitale
Published: (2012-06-01)

Highly sensitive droplet digital PCR for detection of RET fusion in papillary thyroid cancer
by: Mengke Chen, et al.
Published: (2023-04-01)

Ultrasound images-based deep learning radiomics nomogram for preoperative prediction of RET rearrangement in papillary thyroid carcinoma
by: Jialong Yu, et al.
Published: (2022-12-01)

Thermal Ablation of Benign Thyroid Nodules and Papillary Thyroid Microcarcinoma
by: Xiao-Wan Bo, et al.
Published: (2020-10-01)

Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors
by: Jeongwan Kang, et al.
Published: (2020-09-01)

Genetic and clinical profiles of 160 papillary thyroid cancers with lateral neck lymph node metastasis
by: Yiqiao Fang, et al.
Published: (2023-01-01)

Mammary analogue secretory carcinoma: An Indian experience of a novel entity
by: Zeba Nisar, et al.
Published: (2020-01-01)

Case Report: A case of complete response to entrectinib in NTRK fusion gene-positive parotid gland cancer
by: Etsuko Moriyama, et al.
Published: (2023-08-01)

Characterization of an ETV6-NTRK3 rearrangement with unusual, but highly significant FISH signal pattern in a secretory carcinoma of the salivary gland: a case report
by: Florian Wagner, et al.
Published: (2021-08-01)

Larotrectinib treatment for infantile fibrosarcoma in newborns: a case report and literature review
by: Dandan Wang, et al.
Published: (2023-07-01)

Occurrence of paratesticular ganglioneuroma 18 years after concurrent adrenal ganglioneuroma and papillary thyroid carcinoma – a case report
by: Chu-Wen Fang, et al.
Published: (2019-12-01)

Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma
by: Pengfei Gu, et al.
Published: (2022-10-01)

<i>NTRK</i> Fusion Genes in Thyroid Carcinomas: Clinicopathological Characteristics and Their Impacts on Prognosis
by: Barbora Pekova, et al.
Published: (2021-04-01)

Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features
by: Ting Lei, et al.
Published: (2022-12-01)

Warthin-like and classic papillary thyroid cancer have similar clinical presentation and prognosis
by: Roberto Olmos, et al.
Published: (2020-06-01)

Low Prevalence of Somatic Promoter Mutations in Classic Papillary Thyroid Carcinoma
by: Min Ji Jeon, et al.
Published: (2016-03-01)

Ultrasonographic imaging of papillary thyroid carcinoma variants
by: Jung Hee Shin
Published: (2017-04-01)

Initial Experiences of Selective RET Inhibitor Selpercatinib in Adults with Metastatic Differentiated Thyroid Carcinoma and Medullary Thyroid Carcinoma: Real-World Case Series in Korea
by: Han-Sang Baek, et al.
Published: (2023-03-01)

RET/PTC rearrangement in papillary thyroid carcinoma arising in malignant struma ovarii with abdominal wall metastasis and cervical thyroid gland: a case report and review of the literature
by: Maryam Kabootari, et al.
Published: (2023-09-01)

Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report
by: Dan Li, et al.
Published: (2024-04-01)

Our experience with papillary thyroid microcancer
by: Anulekha Mary John, et al.
Published: (2014-01-01)

Aberrant intrathyroidal lymph node metastasis in classical papillary thyroid carcinoma
by: Wan Mohd Nazlee Wan Zainon, et al.
Published: (2021-09-01)

The Impact of ETV6-NTRK3 Oncogenic Gene Fusions on Molecular and Signaling Pathway Alterations
by: Matias Kinnunen, et al.
Published: (2023-08-01)

Iodine nutrition and papillary thyroid cancer
by: Xueqi Zhang, et al.
Published: (2022-10-01)